You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

soluble urokinase plasminogen activator receptor

Showing 1 - 25 of 8,340
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SuPAR in Adult Patients With Covid-19

Completed
  • Covid19
  • Soluble Urokinase Plasminogen Activator Receptor
  • Larissa, Thessaly, Greece
    University Hospital of Larisa, Department of Anesthesiology
Oct 16, 2021

Initial Investigation of Patients With Suspected Pneumonia

Active, not recruiting
  • Pneumonia, Bacterial
  • PCT
  • +2 more
  • Aabenraa, Denmark
    Hospital of Southern Jutland
Apr 19, 2022

Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

Not yet recruiting
  • Pericarditis
  • IL1RA Antibody Assay
  • suPAR Testing
  • Homburg, Germany
  • +8 more
Jun 22, 2023

Plasma Soluble Urokinase Plasminogen Activator Receptor and

Not yet recruiting
  • Behçet Disease
    • (no location specified)
    Jan 11, 2021

    The Role of Ischemia Modified Albumin in Patients With COVID-19

    Recruiting
    • COVID-19
    • Ischemia Modified Albumin
    • Larissa, Thessalia, Greece
      Larissa University Hospital
    May 4, 2022

    Soluble Urokinase Plasminogen Activator Receptor in Non-cardiac

    Completed
    • Surgery--Complications
    • Soluble Urokinase Plasminogen Activator Receptor
    • Larisa, Thessaly, Greece
      University Hospital of Larisa, Department of Anesthesiology
    Nov 11, 2020

    Soluble Urokinase Plasminogen Activation Receptor to Rule Out

    Not yet recruiting
    • Soluble Urokinase Plasminogen Activation Receptor
    • +3 more
    • Soluble Urokinase Plasminogen Activation Receptor measurement
    • Poitiers, France
      CHU of Poitiers
    Jan 5, 2023

    Soluble Urokinase-type Plasminogen Activator Receptor in

    Recruiting
    • Severe Aortic Stenosis or Severe Aortic Regurgitation
      • Seoul, Korea, Republic of
        Division of Cardiology, Severance Cardiovascular Hospital, Yonse
      Nov 26, 2020

      Melatonin, Soluble Urokinase-type Plasminogen Activator

      Unknown status
      • Preterm Premature Rupture of Membranes
      • Obstetric ultrasound and fetal-maternal assessment
      • Gaziantep, Turkey
        Cengiz Gokcek Women's and Children's Hospital
      Oct 8, 2020

      Septic Shock, Sepsis, Severe Trial in Izmir (suPAR)

      Completed
      • Septic Shock
      • Sepsis, Severe
      • suPAR
      • İzmir, Turkey
        Ege University School of Medicine
      Jul 6, 2020

      International Study of Inflammation in COVID-19

      Recruiting
      • Covid19
      • +4 more
      • SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase
      • Ann Arbor, Michigan
        University of Michigan
      Aug 17, 2022

      Esophagus Cancer, Adenocarcinoma Trial in Copenhagen (uPAR immunohistochemistry)

      Completed
      • Esophagus Cancer, Adenocarcinoma
      • uPAR immunohistochemistry
      • Copenhagen, Region Hovedstaden, Denmark
        Rigshospitalet
      Jun 1, 2021

      Triage, Risk Stratification With Biomarker Trial in Herlev (suPAR measurement)

      Completed
      Has Results
      • Triage
      • Risk Stratification With Biomarker
      • suPAR measurement
      • Herlev, Denmark
        Herlev Hospital, Department of Cardiology
      Feb 16, 2021

      Hematopoietic Stem Cell Transplant Trial in Ann Arbor (Cardio-oncology program)

      Not yet recruiting
      • Hematopoietic Stem Cell Transplant
      • Cardio-oncology program
      • Ann Arbor, Michigan
        University of Michigan Rogel Cancer Center
      Jul 6, 2023

      Outcomes of Patients Hospitalized for COVID-19

      Recruiting
      • Covid19
      • +3 more
      • Biomarkers of inflammation
      • Ann Arbor, Michigan
        University of Michigan
      Aug 9, 2022

      Pleural Effusion Trial in United States (LTI-01, Placebo)

      Recruiting
      • Pleural Effusion
      • Birmingham, Alabama
      • +32 more
      Aug 20, 2021

      Contribution of SuPAR forSituation of Uncertainty Downstream of

      Completed
      • Emergencies
      • +2 more
      • blood supar measurement
      • Clermont-Ferrand, France
        CHU clermont-ferrand
      Apr 25, 2022

      Community-acquired Pneumonia, Hospital-acquired Pneumonia Trial in Athens (Anakinra Prefilled Syringe, Placebo)

      Recruiting
      • Community-acquired Pneumonia
      • Hospital-acquired Pneumonia
      • Anakinra Prefilled Syringe
      • Placebo
      • Athens, Greece
      • +1 more
      Mar 14, 2023

      Acute Myocardial Infraction in Patients Without Standard

      Recruiting
      • Cardiovascular Diseases
      • +3 more
      • Investigation of clinical, laboratory and imaging profile
      • Thessaloníki, Central Macedonia, Greece
        AHEPA University Hospital of Thessaloniki
      Sep 6, 2022

      Biomarkers in Acute High-risk AbdoMinAl Surgery

      Completed
      • General Surgery
      • +3 more
      • Emergency abdominal surgery
      • Hvidovre, Capital Region, Denmark
        Hvidovre University hospital
      Aug 4, 2022

      End-stage Heart Failure Trial in Bron (HeartMate 3 TM Left Ventricular Assist System, Guideline Directed Medical Therapy)

      Recruiting
      • End-stage Heart Failure
      • HeartMate 3 TM Left Ventricular Assist System
      • Guideline Directed Medical Therapy
      • Bron, France
        Hôpital Pneumologique et Cardiovasculaire Louis Pradel
      May 17, 2022

      Focal Segmental Glomerulosclerosis Trial in United States (LIPOSORBER® LA-15 System)

      Recruiting
      • Focal Segmental Glomerulosclerosis
      • LIPOSORBER® LA-15 System
      • Loma Linda, California
      • +11 more
      Mar 28, 2022

      HIV, Cardiovascular Disease, AIDS Trial in Atlanta (Let's Move Program, Let's Flex Program, Group Motivational Interviewing)

      Completed
      Has Results
      • HIV
      • +2 more
      • Let's Move Program
      • +2 more
      • Atlanta, Georgia
      • +2 more
      Jun 7, 2022

      Unspecific Symptoms

      Completed
      • Serious Condition
      • Morality
        • Helsinki, Finland
        • +1 more
        Mar 24, 2021

        Cardiovascular Morbidity, Risk Reduction, Nutrition Disorders Trial in Chicago (Vegan diet)

        Completed
        • Cardiovascular Morbidity
        • +2 more
        • Vegan diet
        • Chicago, Illinois
          Rush University Medical Center
        Sep 25, 2021